Concateno bags another acquisition:
This article was originally published in Clinica
UK drug and alcohol testing company Concateno continues to grow its maritime customer base with the acquisition of CPL International Serviced, a provider of alcohol and drugs-of-abuse screening services, as well as immunisation and medical examinations, to the maritime industry. Concateno bought CPL for a cash-and-stock consideration of £840,000 ($1.7m). Liverpool-based CPL, which recorded annual revenues of £433,000 in 2006, is Concateno's fifth purchase this year and comes one month after the latter acquired Marconova, a Swedish lab testing company also focused on the maritime industry, for £2m (see Clinica No 1258, p 14).
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.